[go: up one dir, main page]

ES2059375T3 - Utilizacion del tetrahidrocortisol en la terapia del glaucoma. - Google Patents

Utilizacion del tetrahidrocortisol en la terapia del glaucoma.

Info

Publication number
ES2059375T3
ES2059375T3 ES87304317T ES87304317T ES2059375T3 ES 2059375 T3 ES2059375 T3 ES 2059375T3 ES 87304317 T ES87304317 T ES 87304317T ES 87304317 T ES87304317 T ES 87304317T ES 2059375 T3 ES2059375 T3 ES 2059375T3
Authority
ES
Spain
Prior art keywords
tetrahydrocortisol
glaucoma therapy
glaucoma
therapy
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87304317T
Other languages
English (en)
Inventor
Aaron Louis Southren
Bernard I Weinstein
Gary G Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Medical College
Original Assignee
New York Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College filed Critical New York Medical College
Application granted granted Critical
Publication of ES2059375T3 publication Critical patent/ES2059375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTAN COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN TETRAHIDROCORTISOL Y UN METODO DE USARLO EN EL CONTROL DE LA PRESION INTRAOCULAR.
ES87304317T 1986-05-19 1987-05-15 Utilizacion del tetrahidrocortisol en la terapia del glaucoma. Expired - Lifetime ES2059375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/864,610 US4863912A (en) 1986-05-19 1986-05-19 Use of tetrahydrocortisol in glaucoma therapy

Publications (1)

Publication Number Publication Date
ES2059375T3 true ES2059375T3 (es) 1994-11-16

Family

ID=25343665

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87304317T Expired - Lifetime ES2059375T3 (es) 1986-05-19 1987-05-15 Utilizacion del tetrahidrocortisol en la terapia del glaucoma.

Country Status (8)

Country Link
US (1) US4863912A (es)
EP (1) EP0250088B1 (es)
JP (1) JPH0725679B2 (es)
AT (1) ATE96671T1 (es)
AU (1) AU597660B2 (es)
CA (1) CA1285878C (es)
DE (1) DE3788004T2 (es)
ES (1) ES2059375T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997826A (en) * 1986-05-19 1991-03-05 New York Medical College Tetrahydrocortisol in glaucoma therapy
US5407926A (en) * 1987-12-29 1995-04-18 Alcon Laboratories, Inc. Ophthalmic composition
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
US4945089A (en) * 1987-12-29 1990-07-31 Alcon Laboratories, Inc. Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
US5358943A (en) * 1987-12-29 1994-10-25 Clark Abbot F Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
ES2038344T3 (es) * 1988-01-13 1993-07-16 Schwarz Pharma Ag Soluciones concentradas de corticoesteroides y metodo para su fabricacion.
US5990099A (en) * 1988-10-31 1999-11-23 Alcon Laboratories, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
USRE34578E (en) * 1990-05-07 1994-04-05 Lubkin; Virginia Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
FR2680108B1 (fr) * 1991-08-09 1993-11-19 Theramex Sa Laboratoire Nouvelles compositions pharmaceutiques a base de sterouides 6-hydroxymethyles et leur procede d'obtention.
ATE185071T1 (de) * 1991-06-18 1999-10-15 Theramex Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
FR2679139B1 (fr) * 1991-07-17 1995-03-17 Theramex Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
EP0614463B1 (en) * 1991-11-22 2003-02-12 Alcon Laboratories, Inc. Angiostatic steroids
EP0643581B1 (en) * 1992-04-21 1999-10-20 The Schepens Eye Research Institute, Inc. Ocular androgen therapy in sjögren's syndrome
US6107289A (en) * 1992-04-21 2000-08-22 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
US5376534A (en) * 1993-12-17 1994-12-27 New York Medical College Use of decreased 3-alpha-hydroxysteroid dehydrogenase activity in peripheral lymphocytes or other cells of patients with primary open angle glaucoma as a diagnostic indicator
US5798380A (en) * 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US6586425B2 (en) 1996-02-21 2003-07-01 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US5929111A (en) * 1996-12-18 1999-07-27 Alcon Laboratories, Inc. A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure
US6011023A (en) * 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
GB9914648D0 (en) * 1999-06-24 1999-08-25 Univ Birmingham Control of infra-ocular pressure
US20050239760A1 (en) * 2004-04-23 2005-10-27 Alcon, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension
US20080125406A1 (en) * 2005-10-14 2008-05-29 Robin Alan L Method for Treating Primary and Secondary Forms of Glaucoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones

Also Published As

Publication number Publication date
AU7317387A (en) 1987-11-26
EP0250088A3 (en) 1990-03-28
CA1285878C (en) 1991-07-09
JPH0725679B2 (ja) 1995-03-22
DE3788004D1 (de) 1993-12-09
EP0250088A2 (en) 1987-12-23
AU597660B2 (en) 1990-06-07
EP0250088B1 (en) 1993-11-03
JPS6322021A (ja) 1988-01-29
US4863912A (en) 1989-09-05
ATE96671T1 (de) 1993-11-15
DE3788004T2 (de) 1994-04-07

Similar Documents

Publication Publication Date Title
ES2059375T3 (es) Utilizacion del tetrahidrocortisol en la terapia del glaucoma.
DK582487A (da) Smaapartikel aerosolliposom og liposom-laegemiddelkombinationer til medicinsk anvendelse
IT7968574A0 (it) Dispositivo di infusione impiantabile nel corpo del paziente
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
IT7928079A0 (it) Dispositivo per interventi chirurgici in cavita' del corpo umano.
DK308588D0 (da) Thiophensulfonamid og ophthalmisk praeparat indeholdende en saadan forbindelse
IT8047903A0 (it) Dispositivo per il controllo dell'inclinazione del poggia-testa in una sedia per trattamento
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
GR3006815T3 (es)
AU7426487A (en) Method of treating depression using d-fenfluramine
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
ZA81927B (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
ZA824599B (en) 1-(p-2-isopropoxyethoxymethyl-phenyoxy)-3-isopropylaminopropan-2-01
ZA857721B (en) Process for treatment of rheumatic diseases
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ES2094757T3 (es) Un factor megacariocitopoyetico.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
IT7829846A0 (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare.
IT8821747A0 (it) Espianto per il corroboramento chirurgico della sclera deformata del bulbo oculare.
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 250088

Country of ref document: ES